Additional file 2 of The development of a cSMART-based integrated model for hepatocellular carcinoma diagnosis

Additional file 2: Table S3: Detail information of 345 HCC patients in training cohort. Table S4: Detail information of 344 LC patients in training cohort. Table S5: Detail information of 151 HCC patients in test cohort. Table S6: Detail information of 145 LC patients in test cohort. Table S7: Detail information of 112 HCC patients in validation cohort. Table S8: Detail information of 88 LC patients in validation cohort.

附加文件2：附表S3：训练队列中345例肝细胞癌（Hepatocellular Carcinoma，简称HCC）患者的详细信息；附表S4：训练队列中344例肺癌（Lung Cancer，简称LC）患者的详细信息；附表S5：测试队列中151例HCC患者的详细信息；附表S6：测试队列中145例LC患者的详细信息；附表S7：验证队列中112例HCC患者的详细信息；附表S8：验证队列中88例LC患者的详细信息。